We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Wham | LSE:WAM | London | Ordinary Share | GB00B0JG1P02 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 41.30 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/12/2014 11:51 | Brief post on RUG - hxxp://deepvalueinve Still time to get in - delists today ! | rjmahan | |
04/12/2014 14:43 | Lars Ernest Bader PCI holding mentioned in confusing RNS as 3.63% | praipus | |
02/12/2014 17:33 | "You win some you lose some" Still hold via IPO, ready for when TRX go on a moon shot:) | praipus | |
02/12/2014 17:07 | Sorry to hear that Praipus. Yes, I have my original holding [in profit] plus a trading holding [currently at a loss]. I am a great fan of the ECM technology. The results in the US seem outstanding. They have used their human derived product successfully in patients where previous use of amniotic based products have failed. CMS coding was granted last month allowing invoicing from January. The UK meniscus trial could herald the start of 'off the shelf' biological replacement meniscus, a holy grail of knee surgeons. This could see a reduction in the use of replacement knee joints. | bamboo2 | |
02/12/2014 16:33 | I got out of TRX in July for a 12% loss. Are you still in ? | praipus | |
02/12/2014 16:07 | Strange timing on TRX imo because they finally become a commercial entity in about four weeks! | bamboo2 | |
02/12/2014 15:16 | Thanks bamboo2 great info. Richard Griffiths exiting TRX | praipus | |
02/12/2014 14:30 | Hi Praipus, RGriffiths just sold his entire holding in TRX to Woodford for around £15m. He therefore has lots of cash and could be considering adding further to his existing holdings. cheers | bamboo2 | |
02/12/2014 14:29 | Slater Investments increas DOTD holding to 4.1% | praipus | |
02/12/2014 14:26 | Weiss BBTS holding now 20.03% due to change in voting rights | praipus | |
30/11/2014 20:21 | Might be an opportunity if people get nervous and sell before it delists.... | rjmahan | |
28/11/2014 11:28 | Hi rjm, I followed NJG in to RUG unless I see an exit I intend to stay long. | praipus | |
28/11/2014 00:36 | Praipus posted on Rug thread would love to hear your thoughts - I think there is upside - listed holdings c £1.68 shareprice c£1.21. If anchorfree is half what it is in books for you get your money back - plus chance of some upside... | rjmahan | |
27/11/2014 10:10 | Richard Griffiths still chasing BLNX now holding 7% | praipus | |
25/11/2014 17:10 | Ruffer increasing FIF holding to 17% | praipus | |
24/11/2014 20:09 | Weiss increasing UCP holding to 4.72% | praipus | |
21/11/2014 16:30 | Newton Investments disclosing BSIF holding of 14.99% | praipus | |
21/11/2014 16:27 | Paribas Arbitrage increasing BHUE to 8.34% | praipus | |
21/11/2014 16:24 | Ruffer increasing CRST to 5% | praipus | |
21/11/2014 13:03 | Thank you mrx9000, Slater Investments disclosing a 4.72% holding in CTP Chart added to post #70 | praipus | |
20/11/2014 23:06 | Slater and Wray buying CTP. | mrx9000 | |
19/11/2014 15:48 | Weiss buying a few REH so holding back up to 21.41% | praipus | |
19/11/2014 11:22 | Thank you Epistrophy, re:KUL formerly CGOP and RNS being due to dilution can't believe I missed it: "Issue of new shares" Apologies. | praipus | |
18/11/2014 18:04 | KUL is the new name for CGOP. I think they are not exiting but getting massively diluted by a share issue. | epistrophy | |
18/11/2014 10:03 | Weiss buying some UCP holding 3.97% | praipus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions